Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Picosure Laser System

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

75%

3 of 4 completed with results

Key Signals

3 with results100% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (4)

Trial Status

Completed4

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 4 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT02103153Not ApplicableCompletedPrimary

Clinical Evaluation of the Picosure Laser for the Treatment of Unwanted Tattoos

NCT02110121Not ApplicableCompletedPrimary

Picosure Alexandrite Laser and Revlite Nd:Yag Laser for the Treatment of Unwanted Tattoos

NCT02110095Not ApplicableCompletedPrimary

Picosure Alexandrite Laser for the Treatment of Unwanted Tattoos

NCT02146807Not ApplicableCompletedPrimary

Laser Treatment of Tattoos With Pico Laser

Showing all 4 trials

Research Network

Common Treatments

  • Picosure Laser System3
  • Picosecond Laser System1
  • Revlite Laser System1

Active Sponsors

  • Cynosure, Inc.3
  • Syneron Medical1

Top Investigators

Activity Timeline